# Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin

> **NCT00111982** · PHASE1,PHASE2 · COMPLETED · sponsor: **Amgen** · enrollment: 34 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **BIOLOGICAL:** Liatermin

## Key facts

- **NCT ID:** NCT00111982
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2005-11
- **Final completion:** 2006-02
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2010-02-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00111982

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00111982, "Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of Liatermin". Retrieved via AI Analytics 2026-06-30 from https://api.ai-analytics.org/clinical/NCT00111982. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*